From GlobeNewswire:

Disc Medicine, Inc. is set to present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 10th. John Quisel, the company’s President and CEO, will give the presentation at 2:15 pm PT / 5:15 pm ET. A live webcast will be available on the company’s investor relations website and an archived replay will be accessible after the event. Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company focused on developing treatments for serious hematologic diseases. The company is working on potentially first-in-class therapeutic candidates targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, visit www.discmedicine.com. To learn more about the event, contact Peg Rusconi at [email protected], and for investor relations, contact Christina Tartaglia at [email protected].



Read more: Disc Medicine to Present at the 42nd Annual J.P. Morgan